HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice.
An established relationship exists between human immunodeficiency virus (HIV) and the vascular system, which is characterised by clinical expressions of aneurysmal and occlusive disease that emanate from a common pathological process. The exact pathogenesis is currently unknown; attempts to implicate opportunistic pathogens have been futile. Theories converge on leucocytoclastic vasculitis with the vaso vasora as the vasculopathic epicentre. It is thought that the virus itself or viral proteins trigger the release of inflammatory mediators that cause endothelial dysfunction and smooth muscle proliferation leading to vascular injury and thrombosis. The beneficial effects of highly active anti-retroviral therapy alter the natural history of the disease profile and promote longevity but are negated by cardiovascular complications. Atherosclerosis is an emerging challenge. Presently patients are managed by standard surgical protocols because of non-existent universal surgical interventional guidelines. Clinical response to treatment is variable and often compounded by complications of graft occlusion, sepsis and poor wound healing. The clinical, imaging and pathological observations position HIV-associated large-vessel vasculopathy as a unique entity. This review highlights the spectrum of HIV-associated large-vessel aneurysmal, occlusive and atherosclerotic disease in vascular surgical practice.
Department of Vascular/Endovascular Surgery, Nelson R Mandela School of Medicine, Durban, South Africa.
Balasoobramanien
B
Pillay
Department of Anatomical Pathology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal and National Health Laboratory Service, Durban, South Africa.
Pratistadevi K
PK
Ramdial
Department of Cardiology, University of KwaZulu-Natal, Durban, South Africa.
Datshana P
DP
Naidoo
D000783:Aneurysm / Q000209:etiology / Q000628:therapy*; D000818:Animals; D050197:Atherosclerosis / Q000209:etiology / Q000628:therapy*; D001808:Blood Vessels / Q000276:immunology* / Q000821:virology; D004730:Endothelium, Vascular / Q000276:immunology* / Q000601:surgery / Q000821:virology; D015658:HIV Infections / Q000150:complications / Q000628:therapy*; D006801:Humans; D032389:Myocytes, Smooth Muscle / Q000276:immunology* / Q000473:pathology / Q000821:virology; D017410:Practice Guidelines as Topic; D013927:Thrombosis / Q000209:etiology / Q000628:therapy*; D014656:Vascular Surgical Procedures; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000209:etiology / Q000628:therapy*